Last year in the UK over 60,000 cancer patients enrolled on clinical trials aimed at improving cancer treatments and making them available to all.
A study looking at blood, urine and tissue samples to help diagnose pancreatic cancer and neuroendocrine tumours of the pancreas (ADEPTS)
- pancreatic cancer
- neuroendocrine tumour of the pancreas
More about this trial
- tummy (abdominal) pain
- a swollen tummy
- loss of appetite
- weight loss
- jaundice (yellowing of the skin)
- look for certain proteins (biomarkers)
- find out why some people are more likely to develop cancer than others (genetic predisposition)
Who can enter
- have symptoms that could be due to pancreatic cancer or pancreatic NETs
- have been referred to the multidisciplinary diagnostic centre, gastroenterology clinic or endoscopy unit
- have a high risk of developing pancreatic cancer (your doctor can tell you more about this)
- are going to have an operation for a suspected pancreatic cancer or pancreatic NET
- complete a questionnaire
- have blood and urine tests
- give tissue samples if they have an endoscopy
When possible, you give the blood, urine and tissue samples during routine appointments at the hospital.
If you are part of the group of people with a family history of pancreatic cancer, you visit the hospital every 6 months, for up to 2 years.
You should not have any side effects from taking part in this study.
How to join a clinical trial
Professor Steve Pereira
UCLH Cancer Collaborative
Pancreatic Cancer UK
Fiorina Pancreatic Cancer Fund (Royal Free Charity)
NIHR Clinical Research Network: North Thames